Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality7/10

Lime Q3 Misses, EBITDA Cut; Investigation Adds to Downside Risk

Nov 4, 2026, 7:03 PM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Earnings miss and downgraded guidance typically compress the stock multiple and price; the added overhang from a publicly disclosed investigation amplifies downside risk, as seen in peers during similar events.

AI summary

What happened, with direct paths to the underlying reporting

Neutron Holdings (Lime) posted Q3 diluted EPS of $0.63, missing the $0.66-$0.68 consensus and sending shares lower after hours. Management cited intensified European competition and cut full-year adjusted EBITDA guidance to $253-$255 million from $265-$285 million. A pending investigation into disclosure raises further downside risk and investor anxiety.

LIME Q3 diluted EPS $0.63 vs consensus $0.66-$0.68; shares fell after hours.
CFO: quarterly performance fell short; Europe competition pressures not matched.
FY adjusted EBITDA guidance cut to $253-$255 million from $265-$285 million.
SueWallSt announces pending investigation into disclosure; urges investor loss submissions.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.